Can bringing addiction treatment to syringe programs save more lives?

NCT ID NCT07631598

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether offering buprenorphine treatment directly at syringe service programs (SSPs) helps more people start and stay on medication for opioid use disorder compared to referring them elsewhere. About 512 adults who use SSPs and have moderate to severe opioid use disorder will take part. The goal is to see if on-site, easy-access treatment improves retention and reduces overdoses.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

follicular lymphoma opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alianza of New Mexico

    Roswell, New Mexico, 88203, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • CARPBR/Be Safe Syringe Program

    Baton Rouge, Louisiana, 70806, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Challenges, Inc/Prisma Health

    Greenville, South Carolina, 29605, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Community Health Project Los Angeles (CHPLA)

    Los Angeles, California, 90029, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • HIPS

    Washington D.C., District of Columbia, 20002, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • HIV Alliance

    Grants Pass, Oregon, 97526, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • Harm Reduction Sisters

    Duluth, Minnesota, 55805, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Vivent Health

    Milwaukee, Wisconsin, 53212, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••